A convenient clinically relevant model of human breast cancer bone metastasis (original) (raw)

• Green JR (2003) Antitumor effects of bisphosphonates. Cancer 97:840–847
  Article PubMed Google Scholar
• Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584–593
  Article PubMed CAS Google Scholar
• Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537–549
  Article PubMed CAS Google Scholar
• Minn AJ, Kang Y, Serganova I et al (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44–55
  Article PubMed CAS Google Scholar
• Pécheur I, Peyruchaud O, Serre CM et al (2002) Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J 16:1266–1268
  PubMed Google Scholar
• Peyruchaud O, Serre CM, NicAmhlaoibh R et al (2003) Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J Biol Chem 278:45826–45832
  Article PubMed CAS Google Scholar
• Theilhaber J, Bushnell S, Jackson A et al (2001) Bayesian estimation of fold-changes in the analysis of gene expression: the PFOLD algorithm. J Comput Biol 8:585–614
  Article PubMed CAS Google Scholar
• Roman-Roman S, Garcia T, Jackson A et al (2003) Identification of genes regulated during osteoblastic differentiation by genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone 32:474–482
  Article PubMed CAS Google Scholar
• Schroeder TM, Jensen ED, Westendorf JJ (2005) Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 75:213–225
  Article PubMed CAS Google Scholar
• Sharpless NE, DePinho RA (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5:741–754
  Article PubMed CAS Google Scholar
• Steeg P (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895–904
  Article PubMed CAS Google Scholar
• Eccles SA (2005) Targeting key steps in metastatic tumour progression. Curr Opin Genet Dev 15:77–86
  Article PubMed CAS Google Scholar
• Rosol TJ, Tannehill-Gregg SH, LeRoy BE et al (2003) Animal model of bone metastasis. Cancer 97:748–757
  Article PubMed Google Scholar
• Wetterwald A, van der Pluijm G, Que I et al (2002) Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160:1143–1153
  PubMed Google Scholar
• Kamb A (2005) What’s wrong with our cancer models. Nat Rev Drug Discov 4:161–165
  Article PubMed CAS Google Scholar
• Littlepage LE, Egeblad M, Werb Z (2005) Coevolution of cancer and stromal cellular responses. Cancer cell 7:499–500
  Article PubMed CAS Google Scholar
• Kuperwasser C, Dessain S, Bierbaum BE et al (2005) A mouse model of human breast cancer metastasis to human bone. Cancer Res 65:6130–6138
  Article PubMed CAS Google Scholar
• van’t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536
  Article CAS Google Scholar
• Bourguignon LY, Zhu H, Shao L et al (2000) Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration. J Cell Biol 150:177–191
  Article PubMed CAS Google Scholar
• van der Pluijm G, Sijmons B, Vloedgraven H et al (2001) Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. Am J Pathol 159:971–982
  PubMed Google Scholar
• Matsuura N, Puzon-McLaughlin W, Irie A et al (1996) Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol 148:55–61
  PubMed CAS Google Scholar
• Yoneda T, Sasaki A, Dunstan C et al (1997) Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 99:2509–2517
  PubMed CAS Google Scholar
• Yoneda T, Hiraga T (2005) Crosstalk between cancer cells and bone microenvironment in bone metastasis. BBRC 328:679–687
  PubMed CAS Google Scholar
• Hla T, Lee MJ, Ancellin N et al (2000) Sphingosine-1-phosphate signaling via the EDG-1 family of G-protein-coupled receptors. Ann N Y Acad Sci 905:16–24
  Article PubMed CAS Google Scholar
• Boucharaba A, Serre MC, Gres S et al (2004) Platelet-derived lysophosphatidic acid supports the progession of osteolytic bone metastases in breast cancer. J Clin Invest 114:1714–1725
  Article PubMed CAS Google Scholar
• Li A, Dubey S, Varney ML et al (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376
  PubMed CAS Google Scholar
• Bendre MS, Marguiles AG, Wasler B et al (2005) Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res 65:11001–11009
  Article PubMed CAS Google Scholar
• Kim SJ, Uehara H, Yazici S et al (2005) Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer. Cancer Res 65:3707–3715
  Article PubMed CAS Google Scholar
• Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 28:518–524
  Article CAS Google Scholar
• Segal E, Friedman N, Koller D et al (2004) A module map showing conditional activity of expression modules in cancer. Nat Genet 36:1090–1098
  Article PubMed CAS Google Scholar
• Jones DH, Nakashima T, Sanchez OH et al (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440:692–696
  Article PubMed CAS Google Scholar
• Berg RW, Leung E, Gough S et al (1999) Cloning and characterization of a novel beta integrin-related cDNA coding for the protein TIED (“ten beta integrin EGF-like repeat domains”) that maps to chromosome band 13q33: A divergent stand-alone integrin stalk structure. Genomics 56:169–178
  Article PubMed CAS Google Scholar
• Gettner SN, Kenyon C, Reichardt LF (1995) Characterization of beta pat-3 heterodimers, a family of essential integrin receptors in C. elegans. J Cell Biol 129:1127–1141
  Article PubMed CAS Google Scholar
• Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673–687
  Article PubMed CAS Google Scholar
• Tucker GC (2003) Alpha v integrin inhibitors and cancer therapy. Curr Opin Investig Drugs 4:722–731
  PubMed CAS Google Scholar
• Bellahcene A, Bachelier R, Detry C et al (2006) Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Res Treat 101:135–148
  Article PubMed CAS Google Scholar
• Koeneman KS, Yeung F, Chung LW (1999) Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 39:246–261
  Article PubMed CAS Google Scholar
• Pratap J, Javed A, Languino LR et al (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 25:8581–8591
  Article PubMed CAS Google Scholar